This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bergen Teknologioverføring as. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of Ming Ying
Introduction
Ming Ying is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of pharmacology, particularly in the treatment of hyperphenylalaninemia. His work has the potential to impact the lives of many individuals affected by this condition.
Latest Patents
Ming Ying holds a patent for his invention titled "Hyperphenylalaninemia and treatments thereof." This patent relates to compounds of formula (I) that serve as pharmacological chaperones. These compounds have a stabilizing effect on phenylalanine hydroxylase (PAH) for the treatment of hyperphenylalaninemia, especially phenylketonuria (PKU). The compounds include trimethoprim and its analogues and derivatives. He has 1 patent to his name.
Career Highlights
Throughout his career, Ming Ying has worked with various organizations that focus on technological advancements and innovation. Notably, he has been associated with Bergen Teknologioverføring AS and Vestlandets Innovasjonsselskap AS. His work in these companies has allowed him to contribute to the development of new technologies and solutions in his field.
Collaborations
Ming Ying has collaborated with several professionals in his career, including Aurora Martinez and Oscar Aubi Catevilla. These collaborations have enriched his work and expanded the impact of his inventions.
Conclusion
Ming Ying's contributions to the field of pharmacology, particularly through his patent for treating hyperphenylalaninemia, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile